CRISPR Screens Identify Toxoplasma Genes That Determine Parasite Fitness in Interferon Gamma-Stimulated Human Cells

Toxoplasma infection causes serious complications in immunocompromised individuals and in the developing fetus. During infection, certain immune cells release a protein called interferon gamma that activates cells to destroy the parasite or inhibit its growth. ABSTRACT Toxoplasma virulence depends on its ability to evade or survive the toxoplasmacidal mechanisms induced by interferon gamma (IFNγ). While many Toxoplasma genes involved in the evasion of the murine IFNγ response have been identified, genes required to survive the human IFNγ response are largely unknown. In this study, we used a genome-wide loss-of-function screen to identify Toxoplasma genes important for parasite fitness in IFNγ-stimulated primary human fibroblasts. We generated gene knockouts for the top six hits from the screen and confirmed their importance for parasite growth in IFNγ-stimulated human fibroblasts. Of these six genes, three have homology to GRA32, localize to dense granules, and coimmunoprecipitate with each other and GRA32, suggesting they might form a complex. Deletion of individual members of this complex leads to early parasite egress in IFNγ-stimulated cells. Thus, prevention of early egress is an important Toxoplasma fitness determinant in IFNγ-stimulated human cells. IMPORTANCE Toxoplasma infection causes serious complications in immunocompromised individuals and in the developing fetus. During infection, certain immune cells release a protein called interferon gamma that activates cells to destroy the parasite or inhibit its growth. While most Toxoplasma parasites are cleared by this immune response, some can survive by blocking or evading the IFNγ-induced restrictive environment. Many Toxoplasma genes that determine parasite survival in IFNγ-activated murine cells are known but parasite genes conferring fitness in IFNγ-activated human cells are largely unknown. Using a Toxoplasma adapted genome-wide loss-of-function screen, we identified many Toxoplasma genes that determine parasite fitness in IFNγ-activated human cells. The gene products of four top hits play a role in preventing early parasite egress in IFNγ-stimulated human cells. Understanding how IFNγ-stimulated human cells inhibit Toxoplasma growth and how Toxoplasma counteracts this, could lead to the development of novel therapeutics.

[1]  Steven A. Howell,et al.  A heterotrimeric complex of Toxoplasma proteins promotes parasite survival in interferon gamma-stimulated human cells , 2022, bioRxiv.

[2]  A. Hehl,et al.  Importance of aspartyl protease 5 in the establishment of the intracellular niche during acute and chronic infection of Toxoplasma gondii , 2022, Molecular microbiology.

[3]  M. Dickinson,et al.  Interferon-Inducible E3 Ligase RNF213 Facilitates Host-Protective Linear and K63-Linked Ubiquitylation of Toxoplasma gondii Parasitophorous Vacuoles , 2022, mBio.

[4]  Konstantinos D. Tsirigos,et al.  DeepTMHMM predicts alpha and beta transmembrane proteins using deep neural networks , 2022, bioRxiv.

[5]  J. Söding,et al.  Fast and accurate protein structure search with Foldseek , 2022, bioRxiv.

[6]  S. Ovchinnikov,et al.  ColabFold: making protein folding accessible to all , 2022, Nature Methods.

[7]  Jacob Cohen Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.

[8]  K. Takeda,et al.  A Cluster of Interferon-g-Inducible p65 GTPases Plays a Critical Role in Host Defense against Toxoplasma gondii , 2022 .

[9]  Christopher J. Tonkin,et al.  Transcriptional modification of host cells harboring Toxoplasma gondii bradyzoites prevents IFN gamma-mediated cell death. , 2021, Cell host & microbe.

[10]  C. Hunter,et al.  Lessons from Toxoplasma: Host responses that mediate parasite control and the microbial effectors that subvert them , 2021, The Journal of experimental medicine.

[11]  L. S. Swapna,et al.  ToxoNet: A high confidence map of protein-protein interactions in Toxoplasma gondii reveals novel virulence factors implicated in host cell invasion , 2021, bioRxiv.

[12]  N. Alto,et al.  Over-expression Screen of Interferon-Stimulated Genes Identifies RARRES3 as a Restrictor of Toxoplasma gondii Infection , 2021, bioRxiv.

[13]  Oriol Vinyals,et al.  Highly accurate protein structure prediction with AlphaFold , 2021, Nature.

[14]  Qi Liu,et al.  Genome-Wide CRISPR/Cas9 Screen Identifies New Genes Critical for Defense Against Oxidant Stress in Toxoplasma gondii , 2021, Frontiers in Microbiology.

[15]  L. Sibley,et al.  Toxoplasma gondii secreted effectors co-opt host repressor complexes to inhibit necroptosis. , 2021, Cell host & microbe.

[16]  Musa A. Hassan,et al.  Genome-wide screens identify Toxoplasma gondii determinants of parasite fitness in IFNγ-activated murine macrophages , 2020, Nature Communications.

[17]  Masahiro Yamamoto,et al.  Toxoplasma gondii GRA60 is an effector protein that modulates host cell autonomous immunity and contributes to virulence , 2020, Cellular microbiology.

[18]  L. Sibley,et al.  Toxoplasma gondii secreted effectors co-opt host repressor complexes to inhibit necroptosis , 2020, bioRxiv.

[19]  R. Damoiseaux,et al.  Interferon-mediated reprogramming of membrane cholesterol to evade bacterial toxins , 2020, Nature Immunology.

[20]  J. Wohlschlegel,et al.  Proximity biotinylation reveals novel secreted dense granule proteins of Toxoplasma gondii bradyzoites , 2020, PloS one.

[21]  M. Hakimi,et al.  Toxoplasma GRA15 limits parasite growth in IFNγ‐activated fibroblasts through TRAF ubiquitin ligases , 2020, The EMBO journal.

[22]  Chen Qijun,et al.  Loss of rhoptry protein 9 impeded Toxoplasma gondii infectivity. , 2020, Acta tropica.

[23]  J. McDonald,et al.  Oxysterols provide innate immunity to bacterial infection by mobilizing cell surface accessible cholesterol , 2020, Nature Microbiology.

[24]  G. McFadden,et al.  Division and Adaptation to Host Environment of Apicomplexan Parasites Depend on Apicoplast Lipid Metabolic Plasticity and Host Organelle Remodeling. , 2020, Cell reports.

[25]  M. Hakimi,et al.  Toxoplasma GRA15 limits parasite growth in IFNγ-activated fibroblasts through TRAF ubiquitin ligases , 2020, bioRxiv.

[26]  V. Muralidharan,et al.  An Endoplasmic Reticulum CREC Family Protein Regulates the Egress Proteolytic Cascade in Malaria Parasites , 2020, mBio.

[27]  J. Boothroyd,et al.  Coimmunoprecipitation with MYR1 Identifies Three Additional Proteins within the Toxoplasma gondii Parasitophorous Vacuole Required for Translocation of Dense Granule Effectors into Host Cells , 2020, mSphere.

[28]  D. Mukhopadhyay,et al.  Assays to Evaluate Toxoplasma-Macrophage Interactions. , 2019, Methods in molecular biology.

[29]  Musa A. Hassan,et al.  A genome-wide loss-of-function screen identifies Toxoplasma gondii genes that determine fitness in interferon gamma-activated murine macrophages , 2019, bioRxiv.

[30]  S. Sidik,et al.  In Vivo CRISPR Screen Identifies TgWIP as a Toxoplasma Modulator of Dendritic Cell Migration. , 2019, Cell host & microbe.

[31]  M. Cipriano,et al.  A lipid-binding protein mediates rhoptry discharge and invasion in Plasmodium falciparum and Toxoplasma gondii parasites , 2019, Nature Communications.

[32]  George W. Bell,et al.  Optimizing Systems for Cas9 Expression in Toxoplasma gondii , 2019, mSphere.

[33]  V. Hornung,et al.  Human GBP1 is a microbe‐specific gatekeeper of macrophage apoptosis and pyroptosis , 2019, The EMBO journal.

[34]  J. Boothroyd,et al.  Translocation of Dense Granule Effectors across the Parasitophorous Vacuole Membrane in Toxoplasma-Infected Cells Requires the Activity of ROP17, a Rhoptry Protein Kinase , 2019, mSphere.

[35]  P. Tso,et al.  Apolipoprotein A-IV: A Multifunctional Protein Involved in Protection against Atherosclerosis and Diabetes , 2019, Cells.

[36]  A. Pain,et al.  Global mapping of protein subcellular location in apicomplexans: the parasite as we’ve never seen it before , 2019, Access Microbiology.

[37]  D. Soldati-Favre,et al.  Phosphatidic acid governs natural egress in Toxoplasma gondii via a guanylate cyclase receptor platform , 2019, Nature Microbiology.

[38]  A. Hehl,et al.  An experimental genetically attenuated live vaccine to prevent transmission of Toxoplasma gondii by cats , 2019, Scientific Reports.

[39]  Vincent L. Butty,et al.  Three Toxoplasma gondii Dense Granule Proteins Are Required for Induction of Lewis Rat Macrophage Pyroptosis , 2019, mBio.

[40]  Masahiro Yamamoto,et al.  Toxoplasma Effector TgIST Targets Host IDO1 to Antagonize the IFN-γ-Induced Anti-parasitic Response in Human Cells , 2018, Front. Immunol..

[41]  Robert D. Finn,et al.  HMMER web server: 2018 update , 2018, Nucleic Acids Res..

[42]  Yoshiki Yamaryo-Botté,et al.  Toxoplasma gondii acetyl-CoA synthetase is involved in fatty acid elongation (of long fatty acid chains) during tachyzoite life stages[S] , 2018, Journal of Lipid Research.

[43]  Daniel Veyel,et al.  Interaction of 2′,3′-cAMP with Rbp47b Plays a Role in Stress Granule Formation1[OPEN] , 2018, Plant Physiology.

[44]  V. Carruthers,et al.  Toxoplasma gondii LCAT Primarily Contributes to Tachyzoite Egress , 2018, mSphere.

[45]  S. Sidik,et al.  CRISPR-Cas9-based genome-wide screening of Toxoplasma gondii , 2018, Nature Protocols.

[46]  J. Boothroyd,et al.  Identification of a novel protein complex essential for effector translocation across the parasitophorous vacuole membrane of Toxoplasma gondii , 2018, PLoS pathogens.

[47]  Lukas Zimmermann,et al.  A Completely Reimplemented MPI Bioinformatics Toolkit with a New HHpred Server at its Core. , 2017, Journal of molecular biology.

[48]  I. Coppens,et al.  A novel dense granule protein, GRA41, regulates timing of egress and calcium sensitivity in Toxoplasma gondii , 2017, Cellular microbiology.

[49]  L. Young,et al.  The human immune response to Toxoplasma: Autophagy versus cell death , 2017, PLoS pathogens.

[50]  J. S. Doggett,et al.  Drugs in development for toxoplasmosis: advances, challenges, and current status , 2017, Drug design, development and therapy.

[51]  Haiming Wang,et al.  EuPathDB: the eukaryotic pathogen genomics database resource , 2016, Nucleic Acids Res..

[52]  P. M. Pereira,et al.  K63-Linked Ubiquitination Targets Toxoplasma gondii for Endo-lysosomal Destruction in IFNγ-Stimulated Human Cells , 2016, PLoS pathogens.

[53]  Tim Wang,et al.  A Genome-wide CRISPR Screen in Toxoplasma Identifies Essential Apicomplexan Genes , 2016, Cell.

[54]  A. Bougdour,et al.  Toxoplasma gondii TgIST co-opts host chromatin repressors dampening STAT1-dependent gene regulation and IFN-γ–mediated host defenses , 2016, The Journal of experimental medicine.

[55]  L. Sibley,et al.  Toxoplasma Effector Recruits the Mi-2/NuRD Complex to Repress STAT1 Transcription and Block IFN-γ-Dependent Gene Expression. , 2016, Cell host & microbe.

[56]  J. Wohlschlegel,et al.  The Rhoptry Pseudokinase ROP54 Modulates Toxoplasma gondii Virulence and Host GBP2 Loading , 2016, mSphere.

[57]  D. Soldati-Favre,et al.  Phosphatidic Acid-Mediated Signaling Regulates Microneme Secretion in Toxoplasma. , 2016, Cell host & microbe.

[58]  T. Steinfeldt,et al.  The Toxoplasma gondii rhoptry protein ROP18 is an Irga6‐specific kinase and regulated by the dense granule protein GRA7 , 2015, Cellular microbiology.

[59]  J. Mesirov,et al.  The Molecular Signatures Database Hallmark Gene Set Collection , 2015 .

[60]  I. Coppens,et al.  A Lipolytic Lecithin:Cholesterol Acyltransferase Secreted by Toxoplasma Facilitates Parasite Replication and Egress* , 2015, The Journal of Biological Chemistry.

[61]  R. Xavier,et al.  A Noncanonical Autophagy Pathway Restricts Toxoplasma gondii Growth in a Strain-Specific Manner in IFN-γ-Activated Human Cells , 2015, mBio.

[62]  G. Bett,et al.  The Toxoplasma Dense Granule Proteins GRA17 and GRA23 Mediate the Movement of Small Molecules between the Host and the Parasitophorous Vacuole. , 2015, Cell host & microbe.

[63]  R. Marotta,et al.  Structure of human N-acylphosphatidylethanolamine-hydrolyzing phospholipase D: regulation of fatty acid ethanolamide biosynthesis by bile acids. , 2015, Structure.

[64]  J. Mesirov,et al.  The Molecular Signatures Database (MSigDB) hallmark gene set collection. , 2015, Cell systems.

[65]  Jun S. Liu,et al.  MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens , 2014, Genome Biology.

[66]  L. Sibley,et al.  The Toxoplasma pseudokinase ROP5 forms complexes with ROP18 and ROP17 kinases that synergize to control acute virulence in mice. , 2014, Cell host & microbe.

[67]  A. Sher,et al.  Innate resistance against Toxoplasma gondii: an evolutionary tale of mice, cats, and men. , 2014, Cell host & microbe.

[68]  R. Wek,et al.  GCN2-like eIF2α kinase manages the amino acid starvation response in Toxoplasma gondii. , 2014, International journal for parasitology.

[69]  I. Coppens Exploitation of auxotrophies and metabolic defects in Toxoplasma as therapeutic approaches. , 2014, International journal for parasitology.

[70]  Xing-Quan Zhu,et al.  Geographical patterns of Toxoplasma gondii genetic diversity revealed by multilocus PCR-RFLP genotyping , 2013, Parasitology.

[71]  B. Clough,et al.  Cell Death of Gamma Interferon-Stimulated Human Fibroblasts upon Toxoplasma gondii Infection Induces Early Parasite Egress and Limits Parasite Replication , 2013, Infection and Immunity.

[72]  H. Furuoka,et al.  A novel dense granule protein, GRA22, is involved in regulating parasite egress in Toxoplasma gondii. , 2013, Molecular and biochemical parasitology.

[73]  I. Callebaut,et al.  Toxoplasma gondii Alba proteins are involved in translational control of gene expression. , 2013, Journal of molecular biology.

[74]  L. Sibley,et al.  Exploiting the Unique ATP-Binding Pocket of Toxoplasma Calcium-Dependent Protein Kinase 1 To Identify Its Substrates , 2013, ACS chemical biology.

[75]  I. Coppens,et al.  Characterization of a second sterol‐esterifying enzyme in Toxoplasma highlights the importance of cholesterol storage pathways for the parasite , 2013, Molecular microbiology.

[76]  S. Akira,et al.  Recognition of profilin by Toll-like receptor 12 is critical for host resistance to Toxoplasma gondii. , 2013, Immunity.

[77]  L. Sibley,et al.  Distinct signalling pathways control Toxoplasma egress and host‐cell invasion , 2012, The EMBO journal.

[78]  Michael S. Behnke,et al.  The Polymorphic Pseudokinase ROP5 Controls Virulence in Toxoplasma gondii by Regulating the Active Kinase ROP18 , 2012, PLoS pathogens.

[79]  K. Takeda,et al.  A cluster of interferon-γ-inducible p65 GTPases plays a critical role in host defense against Toxoplasma gondii. , 2012, Immunity.

[80]  M. Yaffe,et al.  The Rhoptry Proteins ROP18 and ROP5 Mediate Toxoplasma gondii Evasion of the Murine, But Not the Human, Interferon-Gamma Response , 2012, PLoS pathogens.

[81]  David M. Rocke,et al.  Transcriptomic Analysis of Toxoplasma Development Reveals Many Novel Functions and Structures Specific to Sporozoites and Oocysts , 2012, PloS one.

[82]  J. Dubey,et al.  Foodborne toxoplasmosis. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[83]  H. Ploegh,et al.  Determinants of GBP Recruitment to Toxoplasma gondii Vacuoles and the Parasitic Factors That Control It , 2011, PloS one.

[84]  D. Lirussi,et al.  RNA Granules Present Only in Extracellular Toxoplasma Gondii Increase Parasite Viability , 2011, International journal of biological sciences.

[85]  J. Ajioka,et al.  Genetic analyses of atypical Toxoplasma gondii strains reveal a fourth clonal lineage in North America. , 2011, International journal for parasitology.

[86]  Kevin A. Robertson,et al.  Host Defense against Viral Infection Involves Interferon Mediated Down-Regulation of Sterol Biosynthesis , 2011, PLoS biology.

[87]  Julia P. Hunn,et al.  Faculty Opinions recommendation of Strain-specific activation of the NF-kappaB pathway by GRA15, a novel Toxoplasma gondii dense granule protein. , 2011 .

[88]  J. Saeij,et al.  Strain-specific activation of the NF-κB pathway by GRA15, a novel Toxoplasma gondii dense granule protein , 2011, The Journal of experimental medicine.

[89]  L. Sibley,et al.  Phosphorylation of Mouse Immunity-Related GTPase (IRG) Resistance Proteins Is an Evasion Strategy for Virulent Toxoplasma gondii , 2010, PLoS biology.

[90]  A. Hidrón,et al.  Cardiac Involvement with Parasitic Infections , 2010, Clinical Microbiology Reviews.

[91]  J. Boothroyd,et al.  Coordinated loading of IRG resistance GTPases on to the Toxoplasma gondii parasitophorous vacuole , 2010, Cellular microbiology.

[92]  C. MacKenzie,et al.  Antimicrobial and immunoregulatory properties of human tryptophan 2,3‐dioxygenase , 2009, European journal of immunology.

[93]  L. Weiss,et al.  Toxoplasmosis: A history of clinical observations. , 2009, International journal for parasitology.

[94]  D. G. Gibson,et al.  Enzymatic assembly of DNA molecules up to several hundred kilobases , 2009, Nature Methods.

[95]  M. Huynh,et al.  Tagging of Endogenous Genes in a Toxoplasma gondii Strain Lacking Ku80 , 2009, Eukaryotic Cell.

[96]  Yang O. Zhao,et al.  Disruption of the Toxoplasma gondii Parasitophorous Vacuole by IFNγ-Inducible Immunity-Related GTPases (IRG Proteins) Triggers Necrotic Cell Death , 2009, PLoS pathogens.

[97]  F. Derouin,et al.  Prevention of toxoplasmosis in transplant patients. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[98]  C. MacKenzie,et al.  Antimicrobial and immunoregulatory effects mediated by human lung cells: role of IFN-gamma-induced tryptophan degradation. , 2008, FEMS immunology and medical microbiology.

[99]  Olivier Martin,et al.  MyHits: improvements to an interactive resource for analyzing protein sequences , 2007, Nucleic Acids Res..

[100]  J. Boothroyd,et al.  Toxoplasma gondii Dysregulates IFN-γ-Inducible Gene Expression in Human Fibroblasts: Insights from a Genome-Wide Transcriptional Profiling1 , 2007, The Journal of Immunology.

[101]  Ulrich Pfeffer,et al.  Identification of Genes Selectively Regulated by IFNs in Endothelial Cells1 , 2007, The Journal of Immunology.

[102]  N. Ueda,et al.  Functional Analysis of the Purified Anandamide-generating Phospholipase D as a Member of the Metallo-β-lactamase Family* , 2006, Journal of Biological Chemistry.

[103]  J. Zerrahn,et al.  Disruption of Toxoplasma gondii Parasitophorous Vacuoles by the Mouse p47-Resistance GTPases , 2005, PLoS pathogens.

[104]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[105]  J. Andersen,et al.  TLR11 Activation of Dendritic Cells by a Protozoan Profilin-Like Protein , 2005, Science.

[106]  S. Brunak,et al.  Improved prediction of signal peptides: SignalP 3.0. , 2004, Journal of molecular biology.

[107]  J. Boothroyd,et al.  Ionophore-resistant mutant of Toxoplasma gondii reveals involvement of a sodium/hydrogen exchanger in calcium regulation , 2004, The Journal of cell biology.

[108]  Kami Kim,et al.  Toxoplasma gondii: the model apicomplexan. , 2004, International journal for parasitology.

[109]  N. Ueda,et al.  Molecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners* , 2004, Journal of Biological Chemistry.

[110]  J. Tobert,et al.  Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors , 2003, Nature Reviews Drug Discovery.

[111]  J. Mornon,et al.  Metallo-β-lactamase fold within nucleic acids processing enzymes: the β-CASP family , 2002 .

[112]  Rachel M. Adams,et al.  The cholesterol-regulated StarD4 gene encodes a StAR-related lipid transfer protein with two closely related homologues, StarD5 and StarD6 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[113]  I. D. Manger,et al.  Microarray Analysis Reveals Previously Unknown Changes in Toxoplasma gondii-infected Human Cells* , 2001, The Journal of Biological Chemistry.

[114]  I. Coppens,et al.  Toxoplasma gondii Exploits Host Low-Density Lipoprotein Receptor-Mediated Endocytosis for Cholesterol Acquisition , 2000, The Journal of cell biology.

[115]  K. Pardhasaradhi,et al.  Mechanisms of interferon-induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells , 1996, Infection and immunity.

[116]  J. Dubey,et al.  Human indoleamine 2,3-dioxygenase inhibits Toxoplasma gondii growth in fibroblast cells. , 1994, Journal of interferon research.

[117]  L. David Sibley,et al.  Virulent strains of Toxoplasma gondii comprise a single clonal lineage , 1992, Nature.

[118]  E. Pfefferkorn,et al.  Interferon-gamma suppresses the growth of Toxoplasma gondii in human fibroblasts through starvation for tryptophan. , 1986, Molecular and biochemical parasitology.

[119]  E. Pfefferkorn Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[120]  J. Messing,et al.  Construction of improved M13 vectors using oligodeoxynucleotide-directed mutagenesis. , 1983, Gene.

[121]  M. Meghji,et al.  Toxoplasmic infection in cardiac disease. , 1979, The American journal of cardiology.

[122]  Y. Kikkawa,et al.  TOXOPLASMA CYSTS IN THE HUMAN HEART, AN ELECTRON MICROSCOPIC STUDY. , 1964, The Journal of parasitology.